Skip to content

Randomized comparison of endoscopic trimodal imaging versus chromoendoscopy guided confocal laser endomicroscopy as surveillance strategy for neoplasia in inflammatory bowel disease of the colon.

Randomized comparison of endoscopic trimodal imaging versus chromoendoscopy guided confocal laser endomicroscopy as surveillance strategy for neoplasia in inflammatory bowel disease of the colon. - ETMI vs CCLE in IBD

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON33215
Enrollment
235
Registered
2009-11-17
Start date
2009-07-01
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colon cancer dysplasia

Interventions

None listed

Sponsors

Academisch Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients with inflammatory bowel disease for more than 8 years. Patients older than 18 year.

Exclusion criteria

Exclusion criteria: Personal history of (partial) colectomy. Contraindications for the use of intravenous fluorescein ( allergy, pregnancy or breastfeeding, sever cardiopulmonary disease or renal failure). Currently known colonic neoplasia (e.g. referred patient or patients who refused treatment of neoplasia in the past). Non-correctable coagulopathy that precludes taking biopsies (international normalized ratio >2 or platelet count

Design outcomes

Primary

MeasureTime frame
To compare endoscopic trimodal imaging (ETMI) vs. chromoendoscopy-guided confocal laser endomicroscopy (CCLE) for differentiating neoplastic from non-neoplastic mucosa in patients with ulcerative colitis (UC).

Secondary

MeasureTime frame
(1) Compare neoplasia detection rates of autofluorescence imaging (AFI) vs. chromoendoscopy (CE) and (2) identify diagnostic endoscopic markers for differentiation between dysplasia associated lesions/masses (DALMs) and adenoma-like masses (ALMs)

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)